Comparing two surgery methods for early-stage thymoma
Part of Cancer clinical trials.
This trial compares two minimally invasive surgery techniques (robotic vs. video-assisted) for removing early-stage thymomas. The goal is to see which approach offers better outcomes and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an early-stage thymoma (a chest tumor) that has not spread.
- Your tumor is no larger than 8 centimeters.
- You are healthy enough for surgery (no major heart, lung, or other organ problems).
- You do not have myasthenia gravis, a condition that causes muscle weakness.
- You have not had previous open-chest surgery (sternotomy).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (hypofractionated) after surgery for people with Stage II or III thymoma or thymic cancer. The goal is to prevent the tumor from coming back.
This trial combines surgery (burning away the tumor) with heated chemotherapy given directly into the chest to treat thymus gland tumors that have spread to the lining of the lung or chest wall. The goal is to remove the visible tumor and wash the area with heated chemo to help delay or prevent it from coming back.
This study tests giving chemotherapy directly into the chest (intrathoracic) during or after surgery to remove pleura tumors in people with thymoma or thymic cancer. It aims to see if this approach can reduce the chance of the cancer coming back.
This study compares two types of minimally invasive surgery for thymoma: one using a robotic system and the other using a tiny camera (VATS). Both aim to remove the tumor with smaller cuts and faster recovery.
This trial compares two ways of surgically removing the thymus: a camera-assisted approach through the chest versus an approach through an opening under the breastbone. It may help people with thymus tumors or certain types of myasthenia gravis when medicines alone have not worked well.
This trial compares two approaches after complete surgical removal of stage IIb or III thymoma: targeted radiation (conformal post-operative radiotherapy) or no further treatment right away (surveillance). It aims to see whether adding radiation lowers the risk of the cancer coming back without causing unacceptable side effects.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.